BsUFA: Industry seeks enhancements for next biosimilars program
Regulatory NewsJoanne S. Eglovitch
Biologics License Application (BLA)Biologics/ biosimilars/ vaccinesBiotechnologyBsUFAHealth Authority meeting and communication strategyQuality Assurance and ControlRegulatory Intelligence/PolicyRegulatory strategyUnited StatesUS Food and Drug Administration (FDA)